1.
Kardiologiia
; 42(9): 26-9, 2002.
Artigo
em Russo
| MEDLINE
| ID: mdl-12494069
Assuntos
Fibrinolíticos/administração & dosagem , Infarto do Miocárdio/tratamento farmacológico , Reperfusão Miocárdica/métodos , Estreptoquinase/administração & dosagem , Feminino , Humanos , Infusões Intravenosas , Injeções Intravenosas/métodos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico por imagem , Radiografia , Fatores de Tempo , Resultado do Tratamento
2.
Klin Med (Mosk)
; 78(1): 37-9, 2000.
Artigo
em Russo
| MEDLINE
| ID: mdl-10697373
RESUMO
ADP-induced platelet aggregation was studied in 28 patients with myocardial infarction randomized, at admission, into three groups. Conventional therapy with heparin and antianginal drugs was combined with aspirin (250 mg/day, n = 9), tiklid (500 mg/day, n = 9), tiklid (500 mg/day) + aspirin (250 mg/day, n = 10) in group 1, 2 and 3, respectively. Tiklid diminished platelet aggregation more effectively than aspirin on the disease day 7 and 21. Tiklid + aspirin combination suppresses platelet aggregation more than monotherapy with either of the drugs, provides insignificant attenuation of postinfarction angina but is associated with a high risk of hemorrhagic complications.